HIV Type-1 Patient's Serum Positive Blood Status was Changed into Serum Negative through 3 Course (One Course for 10 Days) Kallunk Oxide Immunotherapy Treatment

Abstract

The T- cells (CD3+, CD4+, and CD8+) immune response to kallunk oxide [Immunotherapy] treatment could change the HIV type-1 patient’s serum positive blood status into HIV type-1 serum negative. In July- 2015, the most amazing study results as four (4) adult patients were performed through a phase III cost effective intervention clinical study “Traditional Complementary and Alternative Medicine (CAM) in the Treatment of HIV/AIDS” project. This is the recent interim study results (from external laboratories) on the treatment of immunotherapy from a resource limitation country, India